Methylphenidate hydrochloride and Zonisamide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methylphenidate hydrochloride (methylphenidate hydrochloride) and Zonisamide (zonisamide). Common drug interactions include transient ischaemic attack among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Methylphenidate hydrochloride and Zonisamide. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Methylphenidate hydrochloride?
Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 6,822 Methylphenidate hydrochloride users. Check the latest studies of Methylphenidate hydrochloride.
What is Zonisamide?
Zonisamide has active ingredients of zonisamide. It is often used in epilepsy. eHealthMe is studying from 11,445 Zonisamide users. Check the latest studies of Zonisamide.
19 people who take Methylphenidate hydrochloride and Zonisamide together, and have interactions are studied.

What are the common drug interactions of Methylphenidate Hydrochloride and Zonisamide, by gender? *:
female:
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Confusional arousal (behaviours that occur around sleep)
- Facial paralysis (loss of function of face muscle)
- Fine motor delay (delayed movements and actions of the muscles)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Confusional state
- Acne (skin problems that cause pimples)
- Suicidal ideation
- Calculus urinary (stone in urinary system)
male:
- Drug ineffective
- Dyschezia (difficulty in defecating)
- Prostate cancer
What are the common drug interactions of Methylphenidate Hydrochloride and Zonisamide, by age (0-1 to 60+)? *:
0-1:
- Drug ineffective
2-9:
- Aspartate aminotransferase increased
- Blood alkaline phosphatase increased
- Blood lactate dehydrogenase increased
- C-reactive protein increased
- Eosinophil count increased
- Erythema multiforme (a type of hypersensitivity reaction)
- Gamma-glutamyltransferase increased
- Human herpes virus 6 serology positive
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Lymphocyte stimulation test positive
10-19:
n/a
20-29:
n/a
30-39:
- Confusional state
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
- Insomnia (sleeplessness)
- Night sweats (sweating in night)
- Oral herpes (viral infection of mouth)
- Restless legs syndrome (a powerful urge to move your legs)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Somnambulism (sleep walking)
- Tardive dyskinesia (a disorder that involves involuntary movements)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
40-49:
- Peripheral nerve lesion
- Rhinitis allergic (inflammation of the nasal airways due to allergy)
- Calculus urinary (stone in urinary system)
- Contusion (a type of hematoma of tissue in which capillaries)
- Dizziness
- Intervertebral disc displacement
- Mass
- Nasopharyngitis (inflammation of the nasopharynx)
- Paraplegia (paralysis of the legs and lower body)
50-59:
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Flushing (the warm, red condition of human skin)
- Hyperhidrosis (abnormally increased sweating)
60+:
n/a
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 42.11%
- Drowsiness: 7 people, 36.84%
- Bipolar Disorder (mood disorder): 7 people, 36.84%
- Restless Leg Syndrome (a powerful urge to move your legs): 5 people, 26.32%
- Rapid Eye Movements Sleep Abnormal: 5 people, 26.32%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 26.32%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 15.79%
- Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 3 people, 15.79%
- Infantile Spasms: 2 people, 10.53%
- Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take Methylphenidate hydrochloride and Zonisamide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methylphenidate hydrochloride (6,822 reports)
- Zonisamide (11,445 reports)
Browse all drug interactions of Methylphenidate hydrochloride and Zonisamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylphenidate hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zonisamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylphenidate hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zonisamide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride and zonisamide (the active ingredients of Methylphenidate hydrochloride and Zonisamide, respectively), and Methylphenidate hydrochloride and Zonisamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Valsartan cause Glomerular Filtration Rate Decreased? - 5 seconds ago
- Could Remicade cause Injection Site Pruritus? - 5 seconds ago
- Foradil and Dyspnoea for Men aged 50-59 - 15 seconds ago
- Foradil and Dyspnea for Men aged 50-59 - 16 seconds ago
- Lung Neoplasm Malignant and Spinal Cord Compression - 18 seconds ago
- Could Levothroid cause Oedema Aggravated? - 21 seconds ago
- Chantix and Lyrica drug interactions for women aged 40-49 - 26 seconds ago
- Could Warfarin Sodium cause Injection Site Discharge? - 32 seconds ago
- Could Diamox cause Transverse Sinus Thrombosis? - a minute ago
- Benztropine Mesylate and Neutropenia for Men aged 50-59 - a minute ago